novo nordisk glp-1 competition - Stock Newsroom

S TOCK newsroom .COM

S&P 500 6,839 +0.83%

DJIA 48,339 +0.90%

Nasdaq 25,091 +0.79%

DAX 23,928 -0.15%

Gold $4,196 +0.16%

Oil $95.75 -0.97%

BTC $72,426 +1.48%

VIX 20.43 -15.85%

EUR/USD 1.1785 -0.02%

ETH $2,222 +0.59%

S&P 500 6,839 +0.83%

DJIA 48,339 +0.90%

Nasdaq 25,091 +0.79%

DAX 23,928 -0.15%

Gold $4,196 +0.16%

Oil $95.75 -0.97%

BTC $72,426 +1.48%

VIX 20.43 -15.85%

EUR/USD 1.1785 -0.02%

ETH $2,222 +0.59%

novo nordisk glp-1 competition

Novo Nordisk GLP-1 competition visual with obesity pill and injectable pen contrasted on dark background

Pharma & Healthcare·Stocks·Europe

Novo Nordisk GLP-1 competition Warning with new pill rival

By Maik Kemper • Mar 17, 2026

Novo Nordisk GLP-1 competition visual with obesity pill and injectable pen contrasted on dark background

Pharma & Healthcare·Stocks·Europe

Novo Nordisk GLP-1 competition Warning with new pill rival

By Maik Kemper • Mar 17, 2026

Can Novo Nordisk defend its GLP-1 dominance as a potent oral rival emerges and a bold US telehealth deal reshapes distribution? How does Structure Therapeutics…